Mode
Text Size
Log in / Sign up

Ovarian borderline mucinous tumor

Part of Cancer

1 published article · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Cancer

Related studies from across the Cancer family.

Follicular T cell subsets and tertiary lymphoid structures may guide immunotherapy in ovarian cancer
Allergy & Immunology Sys. Review
Follicular T cell subsets and tertiary lymphoid structures may guide immunotherapy in ovarian cancer New immune targets offer hope for ovarian cancer patients
This narrative review synthesizes evidence on follicular T cell subsets, tertiary lymphoid structures, and other immune features in ovarian …
A review highlights new immune system features that could help doctors predict treatment success and find better ways to fight ovarian cance…
Case report of YL205 antibody-drug conjugate in platinum-resistant ovarian carcinoma
Infectious Disease Sys. Review
Case report of YL205 antibody-drug conjugate in platinum-resistant ovarian carcinoma First patient achieves complete response with new ovarian cancer drug YL205
This is a single-patient case report of a 40-year-old woman with platinum-resistant, BRCA-wildtype high-grade serous ovarian carcinoma treat…
A single patient with advanced ovarian cancer achieved a complete response after 24 weeks of treatment with YL205, a new antibody-drug conju…
Review of Mucinous cystic neoplasms of the liver with no reported outcomes or safety data
Orthopedics & Sports Medicine Sys. Review
Review of Mucinous cystic neoplasms of the liver with no reported outcomes or safety data Doctors now know how to safely remove rare liver cysts before they turn cancerous
This narrative review addresses Mucinous cystic neoplasms of the liver. No specific population, sample size, intervention, or outcomes were …
A new review explains how doctors can safely remove rare liver cysts before they turn into cancer
Review of case report suggests multimodal therapy potential for unresectable intraductal papillary mucinous neoplasms of the bile duct
Dermatology Sys. Review
Review of case report suggests multimodal therapy potential for unresectable intraductal papillary mucinous neoplasms of the bile duct At-a-Glance
This review of a case report describes two patients with unresectable intraductal papillary mucinous neoplasms of the bile duct treated with…
A new three-drug combination shrank a rare bile duct tumor in one patient and stopped another from growing, offering hope for a cancer with …
Ovarian cancer diagnoses decreased during COVID-19 pandemic years at a Swiss center
Oncology Cohort
Ovarian cancer diagnoses decreased during COVID-19 pandemic years at a Swiss center Lockdowns Didn't Hurt Ovarian Cancer Survival
This retrospective cohort study of 218 patients at Bern University Hospital found primary ovarian cancer diagnoses decreased in 2020 and 202…
When the world shut down in 2020, hospitals faced a scary reality.
Review highlights diagnostic challenges in testicular mucinous cystic neoplasm management
Oncology Sys. Review
Review highlights diagnostic challenges in testicular mucinous cystic neoplasm management A rare testicular cyst in an older man turned out to be a sign of hidden abdominal cancer
This case report and literature review describes a 78-year-old man who underwent scrotal exploration and right radical orchiectomy for a tes…
A rare testicular cyst in an older man turned out to be a sign of hidden abdominal cancer, highlighting the need for careful follow-up.
Relacorilant plus nab-paclitaxel improves overall survival in platinum-resistant ovarian cancer
Oncology RCT
Relacorilant plus nab-paclitaxel improves overall survival in platinum-resistant ovarian cancer New Drug Combo Extends Survival for Tough Ovarian Cancer Cases
In a phase 3 randomised controlled trial of 381 patients with platinum-resistant ovarian cancer, relacorilant plus nab-paclitaxel significan…
This combination offers a new, simpler option for patients who have run out of standard treatments.
Residual disease after surgery linked to survival in low-grade serous ovarian cancer
Oncology Cohort
Residual disease after surgery linked to survival in low-grade serous ovarian cancer For This Ovarian Cancer, Surgery Is Everything—Chemo May Not Help
This observational retrospective study of 25 patients with low-grade serous ovarian cancer found that residual disease status after primary …
For a rare ovarian cancer, a new study suggests that the quality of surgery is the single most important factor for survival, challenging th…
STAT1 and IL-7 show diagnostic potential for ovarian carcinoma subtypes in cohort study
Allergy & Immunology Cohort
STAT1 and IL-7 show diagnostic potential for ovarian carcinoma subtypes in cohort study Two Tiny Signals Could Help Doctors Tell Apart Two Ovarian Cancers
A cohort study analyzed transcriptome data from 68 patients with high-grade and low-grade serous ovarian carcinoma.
Two tiny gene signals may help doctors distinguish between two ovarian cancer types when biopsy results are unclear, guiding the right treat…
Combined CT morphological and histogram features improve differentiation of PIMA from PINMA compared to separate models
Radiology & Imaging Cohort
Combined CT morphological and histogram features improve differentiation of PIMA from PINMA compared to separate models Combining CT features improved lung cancer subtype prediction accuracy in a small review
This retrospective cohort review evaluated 163 patients with solitary pulmonary invasive mucinous adenocarcinoma (PIMA) or pulmonary invasiv…
Combining CT scan features boosts lung cancer subtype prediction accuracy to 0.845, offering a practical diagnostic aid for distinguishing b…
Retrospective cohort study of 217 surgically treated borderline ovarian tumors in Southern Sweden compares conservative versus complete staging surgery
Oncology Cohort
Retrospective cohort study of 217 surgically treated borderline ovarian tumors in Southern Sweden compares conservative versus complete staging surgery A Gentler Surgery for Ovarian Tumors May Be Safer Than We Thought
This retrospective, population-based cohort review evaluated 217 patients with borderline ovarian tumors (BOT) in Southern Sweden.
A less invasive surgery for borderline ovarian tumors may be just as safe as the standard approach, offering fewer complications without har…
Precision oncology enables targeted therapies for gynecologic cancers, though acquired resistance remains a barrier
Oncology Sys. Review
Precision oncology enables targeted therapies for gynecologic cancers, though acquired resistance remains a barrier Precision oncology advances gynecologic cancer care but resistance remains a major barrier
This systematic review examined the current landscape of precision oncology for patients with endometrial, ovarian, and cervical carcinomas.
Molecular reclassification lets doctors use targeted drugs effectively for gynecologic cancers, but tumor evolution creates a major barrier …